Occurrence of pulmonary thromboembolism during infliximab therapy.
Eklund
K K
KK
Peltomaa
R
R
Leirisalo-Repo
M
M
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D005260:Female; D006801:Humans; D000069285:Infliximab; D008875:Middle Aged; D011655:Pulmonary Embolism / Q000209:etiology*
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab